See how modern identity and access strategies like passwordless authentication are improving clinical efficiency and strengthening security.

Too much of a clinician’s day is still spent navigating access barriers instead of focusing on patient care. It’s time for industry leaders to finally move beyond insufficient, legacy security models. In 2026, the next generation of access management is being shaped by passwordless authentication and modern identity and access strategies.

Digital identity pioneer honored for enabling the Zero Trust security approach and consistently demonstrating the advancement of technologies with Imprivata Identity Governance™

Latest Patents Cover Security and Privacy Issues Associated with Greater Biometric Adoption in the Enterprise

Company Supports Needs of Federal Government Agencies with Strategic Partnerships, Full FIPS 140-2 Compliance and Appointment of Industry Veteran

LEXINGTON, Mass.—August 3, 2010—Imprivata®, Inc., the company that simplifies and secures user access, today announced that it is bringing its expertise to the government market and that its new OneSign® 4.5 product release fully supports FIPS 140-2 compliance. The move comes as a result of the strong demand for single sign-on (SSO) and strong authentication at government agencies and organizations.

Imprivata (NYSE: IMPR) is paying $19.1 million upfront to purchase HT Systems, a Tampa, FL-based maker of a device that can scan the veins in a person’s palms, which helps hospitals and clinics retrieve a patient’s medical records after identifying him or her. Imprivata will pay as much as $6.9 million in the future if the device retains a certain level of clients and hits sales goals.